FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ketamine Injection
Status: Currently in Shortage
»Date first posted: 02/16/2018
»Therapeutic Categories: Anesthesia

Expand all

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 05/16/2022)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg / 20 mL (NDC 67457-181-20) Currently on backorder, next shipment Mid May Mylan label; Sporadic availability expected.
500 mg / 10 mL (NDC 67457-001-10) Available Check wholesalers for inventory
1000 mg / 10 mL (NDC 67457-108-10) Currently on backorder, next shipment Mid June Mylan label; Sporadic availability expected.

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 10 mL vial (NDC 0143-9508-10) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing and will be available in the May 2022 timeframe. Product will be made available as it is released. Demand increase for the drug
100 mg/mL, 5 mL vial (NDC 0143-9509-10) This presentation is currently available. Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.

Hospira, Inc. (Reverified 05/10/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05) Next Delivery: May 2022; Estimated Recovery: December 2022 Demand increase for the drug
500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10) Next Delivery and Estimated Recovery: February 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other

Par Pharmaceutical (Revised 07/07/2021)

Company Contact Information:
201-802-4000

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL MDV (NDC 42023-113-10) Product Available – Please Check Wholesalers for Availability
100 mg/mL, 5 mL MDV (NDC 42023-115-10) Product Available – Please Check Wholesalers for Availability
50 mg/mL, 10 mL MDV (NDC 42023-114-10) Product Available – Please Check Wholesalers for Availability Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English